-
Abstract Number: 2656
Short-Term Effectiveness of a Walk with Ease Program Delivered by Telephone on Arthritis-Related Symptoms, Function, and Physical Activity
-
Abstract Number: 2657
Prevalence of Anxiety, Depression, and Fatigue in Patients with Rheumatic Diseases: A Cross-Sectional Study of 1014 Cases
-
Abstract Number: 2658
Hypovitaminosis D in Lupus Nephitis
-
Abstract Number: 2659
A Comprehensive Approach Utilizing a Combination of Genetics, Cytological Analysis, and Imaging Techniques to Speed up the Diagnostic Process in VEXAS Patients
-
Abstract Number: 2660
Developing Predictive Models for the Diagnosis of VEXAS Syndrome
-
Abstract Number: 2661
Changes in Krebs Von Den Lungen 6 Levels (∆KL6) Predict Fibrosing Progression of Interstitial Lung Disease in Patients with an Underlying Connective Tissue Disease (CTD-ILD)
-
Abstract Number: 2662
In Vivo Generation of B Cell Depleting CAR T Cell Therapies for Treatment of Autoimmune Diseases
-
Abstract Number: 2663
ADI-001: An Allogeneic CD20-targeted γδ CAR T Cell Therapy with Potential for Improved Tissue Homing in Autoimmune Indications
-
Abstract Number: 2664
BCMA-targeted Bispecific T Cell-engager Therapy of Autoimmune Disease
-
Abstract Number: 2665
Autoantibody Titers Against Specific Epitope Peptides Predict Treatment Resistance in Interstitial Lung Disease Associated with Anti-MDA5 Dermatomyositis
-
Abstract Number: 2666
The Risk for Development of Myositis Is Not Increased After COVID-19 Vaccination Among U.S. Veterans
-
Abstract Number: 2667
Anti-Mi2 Autoantibodies in Dermatomyositis Patients Also Recognize Autoimmune Regulator (AIRE) Protein
-
Abstract Number: 2668
Do Levels of anti-Jo1 Autoantibodies Have a Prognostic Role? Longitudinal Assessment of anti-Jo1 and HisRS Protein Levels in a Cohort of anti-Jo1 Positive Patients with Anti-synthetase Syndrome
-
Abstract Number: 2669
Dysferlin Autoantibodies Compromise Sarcolemmal Repair Capacity and Contribute to the Pathogenesis of Idiopathic Immune Myopathies
-
Abstract Number: 2670
Sera from Patients with Idiopathic Inflammatory Myopathy Induces Muscle Weakness, Mitochondrial Dysfunction and Induction of Cytokines in Isolated Skeletal Muscle
ACR Convergence 2024
November 14-19, 2024. Washington, DC.